yttrium has been researched along with Prostatic Neoplasms in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (47.06) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, A; Chun, FKH; Hoeh, B; Karakiewicz, PI; Kluth, LA; Köllermann, J; Kosiba, M; Mandel, P; Preisser, F; Reis, H; Ruppel, D; Smith, K; Wenzel, M; Wild, P | 1 |
| Alcaraz, L; Arévalo, P; Arrowsmith, RL; Bernardo, MS; Caballero, AC; Calatayud, DG; Cortezon-Tamarit, F; Ge, H; Isasi, J; Jardiel, T; Mirabello, V; Pascu, SI; Peiteado, M | 1 |
| Arellano, DL; Chauhan, K; Fournier, PGJ; Hirata, GA; Jain, A; Juárez, P; Sengar, P; Verdugo-Meza, A | 1 |
| Braun, GB; Reich, NO; Shi, Y; Stucky, G; Sun, X; Zhang, F; Zhang, Y; Zhao, D | 1 |
| Gregas, MK; Lauly, B; Scaffidi, JP; Vo-Dinh, T; Zhang, Y | 1 |
| BULKLEY, GJ; COOPER, JA; O'CONOR, VJ | 2 |
| YOUNG, S | 1 |
| FERGUSSON, JD | 1 |
| IRONSIDE, WM; MOSELEY, RD | 1 |
| FESANI, F; GOFFRINI, P; PERACCHIA, A | 1 |
| GREENE, WM | 1 |
| Camey, M; Le Duc, A | 1 |
| Ahlering, T; Lee, IS; Rodgers, LW; Sawyer, DE; Shanberg, AM; Tansey, LA | 1 |
| Fajardo, LF; Kabalin, JN; Mancianti, ML; Terris, MK | 1 |
| DeNardo, GL; DeNardo, SJ; Kukis, DL; Lamborn, KR; Meyers, FJ; Miers, L; O'Donnell, RT | 1 |
| DeNardo, GL; DeNardo, SJ; Kukis, DL; Lamborn, KR; Meyers, FJ; Miers, LA; O'Donnell, RT | 1 |
1 trial(s) available for yttrium and Prostatic Neoplasms
| Article | Year |
|---|---|
Depth of penetration of the neodymium: yttrium-aluminum-garnet laser in the human prostate and clinical results of high-dose laser energy in 50 patients.
Topics: Aged; Aged, 80 and over; Aluminum; Humans; Laser Therapy; Lasers; Male; Middle Aged; Neodymium; Prognosis; Prostate; Prostatectomy; Prostatic Neoplasms; Radiation Dosage; Treatment Outcome; Yttrium | 1995 |
16 other study(ies) available for yttrium and Prostatic Neoplasms
| Article | Year |
|---|---|
The significance of the extent of tissue embedding for the detection of incidental prostate carcinoma on transurethral prostate resection material: the more, the better?
Topics: Aluminum; Carcinoma; Holmium; Humans; Laser Therapy; Male; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Tissue Embedding; Transurethral Resection of Prostate; Treatment Outcome; Urinary Bladder Neck Obstruction; Yttrium | 2022 |
Hybrid Hierarchical Heterostructures of Nanoceramic Phosphors as Imaging Agents for Multiplexing and Living Cancer Cells Translocation.
Topics: Biocompatible Materials; Cell Line, Tumor; Fluorescent Dyes; Humans; Lanthanoid Series Elements; Male; Materials Testing; Nanoparticles; Optical Imaging; Particle Size; Prostatic Neoplasms; Vanadium Compounds; Yttrium | 2021 |
Development of a functionalized UV-emitting nanocomposite for the treatment of cancer using indirect photodynamic therapy.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Female; Folic Acid; Luminescent Agents; Male; Mice; Nanocomposites; Nanoparticles; Neoplasms; Photochemotherapy; Photosensitizing Agents; Prostatic Neoplasms; Protoporphyrins; Reactive Oxygen Species; Silicon Dioxide; Yttrium | 2018 |
Fabrication of Ag@SiO(2)@Y(2)O(3):Er nanostructures for bioimaging: tuning of the upconversion fluorescence with silver nanoparticles.
Topics: Cell Line, Tumor; Europium; Fluorescence; Fluorescent Dyes; Humans; Luminescent Measurements; Male; Materials Testing; Molecular Imaging; Nanostructures; Particle Size; Prostatic Neoplasms; Silicon Dioxide; Silver; Surface Properties; Tissue Distribution; Yttrium | 2010 |
Activity of psoralen-functionalized nanoscintillators against cancer cells upon X-ray excitation.
Topics: Adenine; Apoptosis; Cell Line, Tumor; DNA; Drug Screening Assays, Antitumor; Ficusin; Humans; Male; Nanotechnology; Prostatic Neoplasms; PUVA Therapy; tat Gene Products, Human Immunodeficiency Virus; Thymine; X-Rays; Yttrium | 2011 |
Further experiences in treatment of carcinoma of prostate with radioactive chromic phosphate and yttrium chloride.
Topics: Carcinoma; Chromium; Chromium Compounds; Chromium Radioisotopes; Humans; Male; Phosphates; Prostatic Neoplasms; Yttrium | 1956 |
Pituitary necrosis due to implants of radioactive gold and yttrium.
Topics: Breast; Breast Neoplasms; Gold Radioisotopes; Humans; Male; Pituitary Gland; Prostatic Neoplasms; Yttrium | 1957 |
Further experiences in treatment of carcinoma of prostate with radioactive chromic phosphate and yttrium chloride.
Topics: Carcinoma; Chromium Compounds; Gold Radioisotopes; Humans; Male; Phosphates; Phosphorus; Phosphorus Radioisotopes; Prostatic Neoplasms; Yttrium | 1957 |
Implantation of radioactive material into the pituitary for the control of prostatic cancer: an interim review.
Topics: Humans; Male; Pituitary Diseases; Pituitary Gland; Prostatic Neoplasms; Radioactivity; Yttrium; Yttrium Radioisotopes | 1957 |
Pernasal transsphenoidal yttrium implant of the hypophysis.
Topics: Breast Neoplasms; Humans; Male; Pituitary Gland; Prostatic Neoplasms; Prostheses and Implants; Yttrium; Yttrium Radioisotopes | 1958 |
[Implantation of radioactive yttrium (Y90) in the sella turcica in the treatment of breast and prostate carcinoma in the advanced stage (considerations on 21 cases)].
Topics: Breast; Breast Neoplasms; Humans; Hypophysectomy; Male; Neoplasms; Prostatic Neoplasms; Sella Turcica; Yttrium; Yttrium Radioisotopes | 1959 |
EMBOLIZATION OF DOG PROSTATES WITH YTTRIUM-90 MICROSPHERES.
Topics: Dogs; Embolism; Embolization, Therapeutic; Humans; Male; Microspheres; Neoplasms; Prostatic Neoplasms; Radiation Protection; Research; Yttrium; Yttrium Radioisotopes | 1963 |
Preliminary study of the action of the Yag laser on canine prostatic adenoma and experimental urethral stenosis.
Topics: Adenoma; Animals; Disease Models, Animal; Dogs; Endoscopy; Evaluation Studies as Topic; Laser Therapy; Male; Neodymium; Prostatic Neoplasms; Urethral Stricture; Yttrium | 1980 |
Dosimetry studies utilizing the urolase right-angle firing neodymium:YAG laser fiber in the human prostate.
Topics: Adult; Aged; Aluminum Silicates; Carcinoma, Transitional Cell; Cystectomy; Energy Transfer; Epithelium; Equipment Design; Fiber Optic Technology; Fibrosis; Follow-Up Studies; Hot Temperature; Humans; Laser Coagulation; Male; Metaplasia; Middle Aged; Neodymium; Prostate; Prostatectomy; Prostatic Neoplasms; Time Factors; Urethra; Urinary Bladder Neoplasms; Yttrium | 1996 |
Efficacy and toxicity of radioimmunotherapy with (90)Y-DOTA-peptide-ChL6 for PC3-tumored mice.
Topics: Animals; Antibodies, Monoclonal; Body Weight; Dose-Response Relationship, Radiation; Female; Heterocyclic Compounds; Humans; Leukocyte Count; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Oligopeptides; Platelet Count; Prostatic Neoplasms; Radioimmunotherapy; Radiopharmaceuticals; Specific Pathogen-Free Organisms; Tumor Cells, Cultured; Whole-Body Counting; Yttrium; Yttrium Radioisotopes | 2000 |
Combined modality radioimmunotherapy for human prostate cancer xenografts with taxanes and 90yttrium-DOTA-peptide-ChL6.
Topics: Animals; Combined Modality Therapy; Docetaxel; Heterocyclic Compounds; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Oligopeptides; Paclitaxel; Prostatic Neoplasms; Radiation-Sensitizing Agents; Radioimmunotherapy; Taxoids; Transplantation, Heterologous; Yttrium | 2002 |